Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 20 studies | 38% ± 19% | |
lung | 19 studies | 32% ± 11% | |
peripheral blood | 16 studies | 31% ± 12% | |
eye | 11 studies | 39% ± 14% | |
intestine | 10 studies | 29% ± 13% | |
kidney | 9 studies | 26% ± 5% | |
heart | 5 studies | 28% ± 6% | |
breast | 5 studies | 31% ± 7% | |
liver | 5 studies | 40% ± 13% | |
bone marrow | 4 studies | 26% ± 6% | |
uterus | 4 studies | 37% ± 14% | |
prostate | 4 studies | 30% ± 8% | |
lymph node | 4 studies | 29% ± 9% | |
adipose | 4 studies | 31% ± 7% | |
pancreas | 3 studies | 38% ± 11% | |
skin | 3 studies | 31% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 6229.33 | 2642 / 2642 | 100% | 66.18 | 705 / 705 |
esophagus | 100% | 4054.58 | 1445 / 1445 | 100% | 39.23 | 183 / 183 |
pancreas | 100% | 2530.61 | 328 / 328 | 100% | 43.19 | 178 / 178 |
prostate | 100% | 5607.10 | 245 / 245 | 100% | 52.08 | 502 / 502 |
thymus | 100% | 5824.03 | 653 / 653 | 100% | 62.70 | 605 / 605 |
uterus | 100% | 5884.05 | 170 / 170 | 100% | 53.52 | 459 / 459 |
breast | 100% | 5169.01 | 459 / 459 | 100% | 69.30 | 1117 / 1118 |
lung | 100% | 5436.85 | 578 / 578 | 100% | 41.85 | 1153 / 1155 |
adrenal gland | 100% | 5832.28 | 258 / 258 | 100% | 51.32 | 229 / 230 |
liver | 100% | 2378.97 | 226 / 226 | 100% | 29.57 | 404 / 406 |
bladder | 100% | 4445.29 | 21 / 21 | 99% | 41.18 | 501 / 504 |
kidney | 100% | 4522.56 | 89 / 89 | 99% | 46.80 | 895 / 901 |
ovary | 100% | 7637.45 | 180 / 180 | 99% | 32.60 | 426 / 430 |
intestine | 100% | 4827.61 | 966 / 966 | 99% | 37.62 | 520 / 527 |
stomach | 100% | 3603.20 | 359 / 359 | 99% | 34.68 | 282 / 286 |
skin | 100% | 4329.38 | 1807 / 1809 | 96% | 44.28 | 451 / 472 |
blood vessel | 100% | 4247.07 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 55.21 | 29 / 29 |
muscle | 100% | 4272.44 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 5621.98 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 54.09 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 18.20 | 1 / 1 |
adipose | 100% | 4800.05 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 3169.67 | 848 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 94% | 3682.27 | 873 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 25.42 | 70 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006351 | Biological process | DNA-templated transcription |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005829 | Cellular component | cytosol |
GO_0005886 | Cellular component | plasma membrane |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | GPBP1 |
Protein name | Vasculin (GC-rich promoter-binding protein 1) (Vascular wall-linked protein) Vasculin (GC-rich promoter-binding protein 1) |
Synonyms | hCG_40617 SSH6 GPBP |
Description | FUNCTION: Functions as a GC-rich promoter-specific transactivating transcription factor. . FUNCTION: Functions as a GC-rich promoter-specific transactivating transcription factor. . |
Accessions | ENST00000264779.6 [Q86WP2-2] ENST00000424459.7 ENST00000506184.7 [Q86WP2-1] ENST00000514387.6 [Q86WP2-4] Q86WP2 D4PHA4 ENST00000511209.5 [Q86WP2-3] |